SWKH - Eye On Growth: Robert K Hatcher Adds $55K Of SWK Holdings Stock To Portfolio | Benzinga
A significant insider buy by Robert K Hatcher, Director at SWK Holdings (NASDAQ:SWKH), was executed on July 1, and reported in the recent SEC filing.
What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Monday unveiled that Hatcher made a notable purchase of 3,253 shares of SWK Holdings, valuing at $55,008.
The latest update on Tuesday morning shows SWK Holdings shares down by 0.0%, trading at $16.66.
All You Need to Know About SWK Holdings
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
A Deep Dive into SWK Holdings's Financials
Positive Revenue Trend: Examining SWK Holdings's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.16% as of 31 March, 2024, showcasing ...